NEUP

5.72

1.38% -0.08

Handel nachbörslich: 5.70 -0.02 -0.35%

Neuphoria Therapeutics Inc (NEUP)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$5.80

Offen:

24-Stunden-Volumen:

54,814

Relative Volume:

0.11

Marktkapitalisierung:

$10.19M

Einnahmen:

Nettoeinkommen (Verlust:

KGV:

EPS:

Netto-Cashflow:

1W Leistung:

+6.32%

1M Leistung:

+10.21%

6M Leistung:

+0.00%

1J Leistung:

+0.00%

1-Tages-Spanne:

$5.63

$6.05

1-Wochen-Bereich:

$5.3054

$6.1231

52-Wochen-Spanne:

$2.90

$12.55

Neuphoria Therapeutics Inc Stock (NEUP) Company Profile

Firmenname

Neuphoria Therapeutics Inc

Sektor

Healthcare (1166)

Branche

Biotechnology (671)

Telefon

61 8 8150 7400

Adresse

200 GREENHILL ROAD, EASTWOOD SA

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NEUP's Discussions on Twitter

Vergleichen Sie NEUP mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NEUP Neuphoria Therapeutics Inc	5.72	10.19M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	492.69	131.41B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	637.36	72.26B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	589.15	35.93B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	268.46	34.75B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	267.39	28.24B	3.81B	-644.79M	-669.77M	-6.24

Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-09-28	Hochstufung	H.C. Wainwright	Neutral → Buy
2023-09-28	Bestätigt	Maxim Group	Buy
2022-01-10	Eingeleitet	Berenberg	Buy
2022-01-10	Eingeleitet	Cantor Fitzgerald	Overweight
2022-01-10	Eingeleitet	Evercore ISI	Outperform
2022-01-10	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Neuphoria Therapeutics Inc Aktie (NEUP) Neueste Nachrichten

Mar 03, 2025

Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025 - GlobeNewswire

Mar 03, 2025

Neuphoria Therapeutics Inc Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Mar 03, 2025

Neuphoria Therapeutics Inc Rings the Opening Bell - Nasdaq

Mar 03, 2025

Feb 26, 2025

Neuphoria Stock Jumps On Triggering $15M Milestone Payment From Merck For Alzheimer's Study: Retail Interest Explodes - MSN

Feb 26, 2025

Feb 23, 2025

Neuphoria Therapeutics rises on $15 mln milestone payment from Merck - TradingView

Feb 12, 2025

Neuphoria Therapeutics shares surge on $15M Merck payment - MSN

Feb 12, 2025

Neuphoria receives $15M milestone payment from Merck - MSN

Feb 12, 2025

Neuphoria To Receive $15 Mln Milestone Payment From Merck; Stock Up In Pre-market - Nasdaq

Feb 12, 2025

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck - GlobeNewswire

Feb 12, 2025

Neuphoria Therapeutics to receive $15M milestone payment from Merck - MSN

Feb 12, 2025

Neuphoria Therapeutics shares surge on $15M Merck payment By Investing.com - Investing.com Australia

Feb 12, 2025

Feb 09, 2025

Here's Why Momentum in Neuphoria Therapeutics Inc. (NEUP) Should Keep going - MSN

Feb 09, 2025

Neuphoria Therapeutics Takes the Biotech Spotlight: U.S. Relocation and Nasdaq Debut Promise Game-Changing Opportunities - Jomfruland.net

Feb 09, 2025

Feb 07, 2025

Neuphoria Therapeutics Inc. – Common Stock (NASDAQ:NEUP) Given New $21.00 Price Target at HC Wainwright - Armenian Reporter

Feb 07, 2025

Brokers Set Expectations for NEUP Q2 Earnings - Defense World

Feb 07, 2025

Feb 06, 2025

HC Wainwright Forecasts Strong Price Appreciation for Neuphoria Therapeutics Inc. – Common Stock (NASDAQ:NEUP) Stock - Defense World

Feb 06, 2025

FY2027 Earnings Estimate for NEUP Issued By HC Wainwright - Defense World

Feb 06, 2025

Jan 28, 2025

Why Neuphoria Therapeutics Inc. (NEUP) Surged on Friday - MSN

Jan 28, 2025

Jan 25, 2025

10 Firms Defy Market Pessimism - Insider Monkey

Jan 25, 2025

Jan 24, 2025

Stock market news: Nvni Group +254.36%, Allurion Technologies +153.92% among top gainers during mid day trading - Business Upturn

Jan 24, 2025

Stock market news: Neuphoria Therapeutics and Nvni Group saw surge of 134.96% and 245.64% concurrently during mid day trading - Business Upturn

Jan 24, 2025

Jan 15, 2025

Neuphoria Therapeutics regains Nasdaq compliance - Investing.com India

Jan 15, 2025

Neuphoria Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Australia

Jan 15, 2025

Jan 09, 2025

Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder - Marketscreener.com

Jan 09, 2025

Bionomics Trades 1.8% Lower in Premarket Activity Tuesday After Surging 46% in Previous Regular Trading Session - Marketscreener.com

Jan 09, 2025

Bionomics Limited announced that it expects to receive $70 million in funding - Marketscreener.com

Jan 09, 2025

Bionomics Limited to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting - Marketscreener.com

Jan 09, 2025

Bionomics Limited Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder - Marketscreener.com

Jan 09, 2025

Jan 08, 2025

NEUP (Neuphoria Therapeutics) Cash From Other Investing Act - GuruFocus.com

Jan 08, 2025

Jan 06, 2025

NEUP (Neuphoria Therapeutics) Cash From Discontinued Investing Activities : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Jan 06, 2025

Dec 27, 2024

Why Evaxion Biotech Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 27, 2024

Dec 26, 2024